Drospirenone And Ethinyl Estradiol
Product Images NDC 53002-1735

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Drospirenone And Ethinyl Estradiol (NDC 53002-1735). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister

Illustration showing a hand peeling back a foil on a blister pack of drospirenone and ethinyl estradiol tablets USP, 3 mg/0.02 mg. The blister pack is organized in a weekly layout with days of the week labeled from Tuesday to Monday across four weeks. Usage instructions begin with 'Start Week 1' at the top left. A caution note at the bottom states that the package is not child resistant.*

FDA Label Image

Figure1

A forest plot showing hazard ratios, rate ratios, and odds ratios for multiple studies, grouped into Prospective Cohort Studies, Retrospective Cohort Studies, Case-Control Studies, and Non-fatal idiopathic cases only. Each study is represented by a black diamond with confidence intervals along a logarithmic scale axis ranging from 0.1 to 10.*

FDA Label Image

Figure2

A horizontal bar chart showing the number of women with a blood clot per 10,000 women-years (WY) for four groups: Non-Pregnant Non-COC User (1 to 5), COC-User (3 to 9), Pregnancy (5 to 20), and Postpartum (12 weeks only) with the highest range (40 to 65). A note explains the pregnancy duration basis for the data.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure Drospirenone

Chemical structure of the active ingredient drospirenone, showing its steroid backbone with oxygen-containing functional groups and characteristic ring formations.*

FDA Label Image

Structure Ethinyl

Chemical structure diagram of ethinyl estradiol, showing its molecular framework with rings and hydroxyl groups.*

FDA Label Image

Chart

An illustration showing a vertical scale indicating pregnancy rates from 'More Pregnancies' at the bottom to 'Fewer Pregnancies' at the top. Different contraceptive methods are listed along the scale, with implants, injections, intrauterine devices, and sterilization at the top (fewer pregnancies), birth control pills, skin patch, and vaginal ring in the middle, condoms and diaphragm below that, and no sex during fertile days, spermicide, withdrawal, and no birth control towards the bottom (more pregnancies). The scale includes pregnancy rates per 100 women per year on the left side.*

FDA Label Image

Label Image (Lbl530021735)

Packaging label for drospirenone and ethinyl estradiol 3 mg and 0.02 mg tablets by RPK Pharmaceuticals, Inc. The label indicates a supply of 28 tablets with a prescribed dosage of one tablet daily. It includes spaces for patient name and clinic information, along with NDC number 53002-1735-1 and barcodes. Additional lot and billing information is visible on the label.*

FDA Label Image

Serious Blood Clot

A horizontal bar chart comparing the number of women with a blood clot per 10,000 women-years (WY) among four groups: Non-Pregnant Non-COC Users, COC Users, Pregnant women, and women 12 weeks Postpartum. Each bar shows a range of blood clot cases, with Non-Pregnant Non-COC Users ranging from 1 to 5, COC Users from 3 to 9, Pregnant from 5 to 20, and Postpartum from 40 to 65, including a note on pregnancy duration assumptions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.